Colgate-Palmolive (CL) Shares Sold by Garcia Hamilton & Associates LP DE
Garcia Hamilton & Associates LP DE cut its position in shares of Colgate-Palmolive (NYSE:CL) by 39.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,535 shares of the company’s stock after selling 8,177 shares during the quarter. Colgate-Palmolive accounts for about 1.3% of Garcia Hamilton & Associates LP DE’s investment portfolio, making the stock its 22nd largest holding. Garcia Hamilton & Associates LP DE’s holdings in Colgate-Palmolive were worth $929,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Pacer Advisors Inc. lifted its stake in Colgate-Palmolive by 8.4% in the second quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock valued at $1,499,000 after buying an additional 1,566 shares during the last quarter. Alliancebernstein L.P. lifted its stake in Colgate-Palmolive by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after buying an additional 77,414 shares during the last quarter. Israel Discount Bank of New York bought a new stake in Colgate-Palmolive in the first quarter valued at $1,349,000. Principal Financial Group Inc. lifted its stake in Colgate-Palmolive by 0.6% in the first quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after buying an additional 7,905 shares during the last quarter. Finally, Personal Capital Advisors Corp lifted its stake in Colgate-Palmolive by 5.8% in the second quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock valued at $29,209,000 after buying an additional 21,456 shares during the last quarter. Hedge funds and other institutional investors own 72.96% of the company’s stock.
A number of equities research analysts have issued reports on the company. Jefferies Group reiterated a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Societe Generale cut Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price on the stock. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Finally, Macquarie assumed coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have issued a buy rating to the company’s stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $76.04.
Shares of Colgate-Palmolive (NYSE CL) opened at $73.32 on Friday. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. The firm has a market cap of $64,382.66, a PE ratio of 25.55, a P/E/G ratio of 3.36 and a beta of 0.81.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. Colgate-Palmolive’s revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.73 earnings per share. research analysts predict that Colgate-Palmolive will post 2.88 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s payout ratio is currently 61.78%.
ILLEGAL ACTIVITY WARNING: This news story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/12/10/colgate-palmolive-cl-shares-sold-by-garcia-hamilton-associates-lp-de.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.